Association between autonomic nervous dysfunction and cellular inflammation in end-stage renal disease

Table 7 Expression density of acetylcholine receptor (AChR) on CD14+ monocytes, CD3+ T-cells, and CD19+ B-cells

	Controls	Diabetic HD	Nondiabetic HD	All HD
AChR/CD14+ Monocytes (MFI)	7.0 [1.8]	15.4 [6.9]*	15.3 [3.3]**	15.4 [5.2]
AChR/CD3+ T-Lymphocytes (MFI)	14.3 [8.3]	15.9 [5.3]	11.7 [5.3]	13.1 [5.9]
AChR/CD19+ B- Lymphocytes (MFI)	10.8 [3.0]	13.3 [5.3]	14.3 [8.4]	14.2 [5.7]

* = p < 0.05 vs. controls; **p < 0.01 vs. controls by Kruskal-Wallis and Dunn’s test. Statistical tests were done for the three groups controls, diabetic and nondiabetic patients. The column “all HD” remained untested. MFI: Mean fluorescence intensity

ISSN: 1471-2261